Anti-oxidant therapy in non-alcoholic fatty liver disease: the role of silymarin

被引：16
|
作者：
Abenavoli, Ludovico [1 ]
Milic, Natasa [2 ]
Capasso, Francesco [3 ]
机构：
[1] Magna Graecia Univ Catanzaro, Dept Hlth Sci, I-88100 Catanzaro, Italy
[2] Univ Novi Sad, Dept Pharm, Novi Sad 21000, Serbia
[3] Univ Naples Federico II, Dept Expt Pharmacol, I-80131 Naples, Italy
来源：
ENDOCRINE | 2012年 / 42卷 / 03期
关键词：
Insulin Resistance; Silymarin; Free Fatty Acid Level; Silibinin; Favorable Safety Profile;
D O I：
10.1007/s12020-012-9677-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：754 / 755
页数：2
相关论文
共 50 条
  • [1] Anti-oxidant therapy in non-alcoholic fatty liver disease: the role of silymarin
    Ludovico Abenavoli
    Natasa Milic
    Francesco Capasso
    Endocrine, 2012, 42 : 754 - 755
  • [2] Role of silymarin to treat fibrosis development in non-alcoholic fatty liver disease
    Abenavoli, Ludovico
    HEPATOLOGY RESEARCH, 2011, 41 (07) : 668 - 668
  • [3] Silymarin: An option to treat non-alcoholic fatty liver disease
    Colica, Carmela
    Boccuto, Luigi
    Abenavoli, Ludovico
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (47) : 8437 - 8438
  • [4] Silymarin: An option to treat non-alcoholic fatty liver disease
    Carmela Colica
    Luigi Boccuto
    Ludovico Abenavoli
    World Journal of Gastroenterology, 2017, (47) : 8437 - 8438
  • [5] Silymarin in non alcoholic fatty liver disease
    Cacciapuoti, Fulvio
    Scognamiglio, Anna
    Palumbo, Rossella
    Forte, Raffaele
    Cacciapuoti, Federico
    WORLD JOURNAL OF HEPATOLOGY, 2013, 5 (03) : 109 - 113
  • [6] Silymarin in non alcoholic fatty liver disease
    Fulvio Cacciapuoti
    Anna Scognamiglio
    Rossella Palumbo
    Raffaele Forte
    Federico Cacciapuoti
    World Journal of Hepatology, 2013, (03) : 109 - 113
  • [7] The Effect of Mycotoxins and Silymarin on Liver Lipidome of Mice with Non-Alcoholic Fatty Liver Disease
    Bechynska, Kamila
    Kosek, Vit
    Fenclova, Marie
    Muchova, Lucie
    Smid, Vaclav
    Suk, Jakub
    Chalupsky, Karel
    Sticova, Eva
    Hurkova, Kamila
    Hajslova, Jana
    Vitek, Libor
    Stranska, Milena
    BIOMOLECULES, 2021, 11 (11)
  • [8] Future therapy for non-alcoholic fatty liver disease
    Issa, Danny
    Patel, Vaishali
    Sanyal, Arun J.
    LIVER INTERNATIONAL, 2018, 38 : 56 - 63
  • [9] DIET THERAPY OF NON-ALCOHOLIC FATTY LIVER DISEASE
    Topilskaya, N.
    Isakov, V.
    Kaganov, B.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S522 - S522
  • [10] Role of ezetimibe in non-alcoholic fatty liver disease
    Filippatos, Theodosios D.
    Elisaf, Moses S.
    WORLD JOURNAL OF HEPATOLOGY, 2011, 3 (10) : 265 - 267
12345